Sectra ABMIL:1SECT 78 ROC (Joel Greenblatt) % is 228.55% as of Apr. 2026, which is 20% below its 10-year median of 287.37. GuruFocus rates MIL:1SECT with a GF Score™ of 78/100 and a GF Value™ of €28.93 (Fairly Valued). Among 841 Medical Devices & Instruments companies, Sectra AB ranks better than 99.29% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sectra AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 228.55%.
The historical rank and industry rank for Sectra AB's ROC (Joel Greenblatt) % or its related term are showing as below:
MIL:1SECT'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 206.59 Med: 287.37 Max: 600.35
Current: 206.59
During the past 13 years, Sectra AB's highest ROC (Joel Greenblatt) % was 600.35%. The lowest was 206.59%. And the median was 287.37%.
MIL:1SECT's ROC (Joel Greenblatt) % is ranked better than 99.29% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 4.13
vs MIL:1SECT: 206.59
Sectra AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -5.30% per year.
Sectra AB (MIL:1SECT) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Sectra AB's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1SECT vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Sectra AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Sectra AB's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 228.55% mean?
Sectra AB (MIL:1SECT) has a ROC (Joel Greenblatt) % of 228.55% as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sectra AB and its competitors. This is 20% below median its historical median of 287.37. Over the past decade, Sectra AB's ROC (Joel Greenblatt) % has ranged from 206.59 to 600.35. According to the industry distribution chart, Sectra AB ranks #6 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 0.7%.
Is Sectra AB's ROC (Joel Greenblatt) % too high?
Sectra AB's current ROC (Joel Greenblatt) % of 228.55% is 20% below median its 10-year median of 287.37. Over the past 10 years, this metric has ranged from a low of 206.59 to a high of 600.35. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.13. Sectra AB's value of 228.55% is 5433.9% above this industry median. Based on the distribution chart, Sectra AB ranks #6 out of 841 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #6 out of 841 companies for ROC (Joel Greenblatt) %. This places Sectra AB in the top 1% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.13. Sectra AB's value of 228.55% is 5433.9% above this benchmark. Historically, Sectra AB's own ROC (Joel Greenblatt) % has ranged from 206.59 to 600.35 over the past decade. While the company's 10-year median is 287.37 vs. the industry median of 4.13, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.13, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current ROC (Joel Greenblatt) % of 228.55% is 5433.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current ROC (Joel Greenblatt) % is 228.55%, which is 20% below median its own 10-year median of 287.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 228.55%, which is 20% below median its 10-year median of 287.37 and 5433.9% above the Medical Devices & Instruments industry median of 4.13. Sectra AB's overall GF Score™ is 78/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current ROC (Joel Greenblatt) % is 228.55% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
ROC (Joel Greenblatt) %: 228.55% (20% below median its 10-year median of 287.37)
GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
Industry Position: 5433.9% above the Medical Devices & Instruments median (#6 of 841)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
78GF Score
Get the complete analysis for MIL:1SECT
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 
